Juzentaihoto improves adenine-induced chronic renal failure in BALB/c mice via suppression of renal fibrosis and inflammation
Renal inflammation and fibrosis are observed in underlying diseases associated with the pathological progression of chronic kidney disease (CKD). The inhibition of renal inflammation and fibrosis is one method to suppress the progression of CKD. Juzentaihoto (TJ-48), a Kampo medicine, effectively re...
Saved in:
Main Authors: | Satoyasu Ito (Author), Eri Manabe (Author), Yi Dai (Author), Masaharu Ishihara (Author), Takeshi Tsujino (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation
by: Kojiro Takamoto, et al.
Published: (2021) -
Effect of acetaminophen on progression of renal damage in adenine-induced renal failure model rat
by: Daisuke Kadowaki, et al.
Published: (2012) -
Adenine-rich diet: a potential mechanism for renal fibrosis progression
by: Majid Malaki
Published: (2022) -
Recombinant Erythropoietin Provides Protection against Renal Fibrosis in Adenine-Induced Chronic Kidney Disease
by: Estefanía Vázquez-Méndez, et al.
Published: (2020) -
Dapagliflozin alleviates renal fibrosis in a mouse model of adenine-induced renal injury by inhibiting TGF-β1/MAPK mediated mitochondrial damage
by: Jianhua Zeng, et al.
Published: (2023)